The authors would like to thank Yolanda Carolina Carmona Carballo, Suemy Analí Gutiérrez Martín, Eduardo José Geded Moreno, and Ana Laura Marrufo Tamayo for their dedication and efforts. Thanks are extended to Drs. James W. Austin of BASF Corporation and Susanne Stutz of BASF SE, Professional & Specialty Solutions division for providing Sylando 240SC for this trial and for consultation on unique properties of chlorfenapyr prior to study initiation.